To whom should adverse drug events be reported?

Adverse drug events (ADEs) should be reported to MedWatch and other relevant health authority agencies because these organizations are specifically designed to collect and analyze information regarding the safety of medications. MedWatch is the FDA's safety information and adverse event reporting program, which allows healthcare professionals and the public to report ADEs. By submitting reports to such agencies, valuable data can be gathered that helps identify potential safety issues, facilitates regulatory actions, and informs both healthcare providers and patients about these risks. This reporting is essential for maintaining drug safety, ensuring that any adverse effects are tracked and managed appropriately across the healthcare community.